AR
Publications
121
Views
76,584
Downloads
13,645
Supervised works
4
Items per page
1 - 121 of 121
Title Published in Access level OA Policy Year Views Downloads
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancerBMC cancer
accessLevelPublic
2022 251 104
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?Current treatment options in oncology
accessLevelPublic
2022 91 27
Prostate cancer nonascitic peritoneal carcinomatosis after robot-assisted laparoscopic radical prostatectomy: 3 case reports and review of the literatureUrology
accessLevelRestricted
2020 318 0
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanomaScientific Reports
accessLevelPublic
2019 270 813
Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical reviewCritical reviews in oncology/hematology
accessLevelRestricted
2018 323 0
Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinomaDigestive and Liver Disease
accessLevelRestricted
2017 544 1
Reversibility of Chemotherapy-Related Liver InjuryJournal of hepatology
accessLevelRestricted
2017 712 0
Prise en charge multidisciplinaire du cancer localisé du rectumRevue médicale suisse
accessLevelPublic
2017 784 383
Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancerDigestive and Liver Disease
accessLevelRestricted
2017 523 0
Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon CancerClinical cancer research
accessLevelRestricted
2016 541 4
Management of patients with colorectal liver metastasis in eleven questions and answersExpert review of anticancer therapy
accessLevelRestricted
2016 773 2
Epidémiologie, prise en charge et suivi des polypes colorectauxRevue médicale suisse
accessLevelRestricted
2016 517 1
Prise en charge de la carcinose péritonéale par chirurgie cytoréductive et chimiothérapie hyperthermique intrapéritonéaleRevue médicale suisse
accessLevelPublic
2016 852 405
Single Nucleotide Polymorphism (rs4932178) in the P1 Promoter of FURIN Is Not Prognostic to Colon CancerBioMed research international
accessLevelPublic
2015 547 246
Rectal Outcomes After a Liver-First Treatment of Patients with Stage IV Rectal CancerAnnals of surgical oncology
accessLevelRestricted
2015 911 0
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trialAnnals of oncology
accessLevelRestricted
2015 576 0
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trialLancet
accessLevelRestricted
2015 624 0
Response to:Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression dataJournal of the National Cancer Institute
accessLevelRestricted
2015 523 0
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistanceMolecular oncology
accessLevelRestricted
2015 543 0
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)Annals of oncology
accessLevelRestricted
2015 594 1
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers InitiativeEuropean journal of cancer
accessLevelPublic
2015 598 316
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal CancerClinical colorectal cancer
accessLevelPublic
2015 749 618
Cancers superficiels de l'œsophage : épidémiologie, diagnostic et traitementRevue médicale suisse
accessLevelRestricted
2015 480 3
Création du Centre du cancer de la prostate des HUGRevue médicale suisse
accessLevelRestricted
2014 752 2
Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristicsAsia-Pacific journal of clinical oncology
accessLevelRestricted
2014 603 0
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical featuresAnnals of oncology
accessLevelRestricted
2014 669 0
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectumEuropean journal of cancer
accessLevelRestricted
2014 580 3
Cancers superficiels de l'estomac : épidémiologie, diagnostic et prise en chargeRevue médicale suisse
accessLevelRestricted
2014 569 0
Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancerBMC surgery
accessLevelPublic
2014 911 222
European perspective for effective cancer drug developmentNature Reviews Clinical Oncology 1759-4782]
accessLevelRestricted
2014 700 0
Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional controlInternational journal of radiation oncology, biology, physics
accessLevelRestricted
2013 642 0
EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in EuropeEuropean journal of cancer
accessLevelRestricted
2013 558 1
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancerJournal of pathology
accessLevelPublic
2013 583 1,573
Registry of gastric cancer treatment evaluation (REGATE): II treatment practiceAsia-Pacific journal of clinical oncology
accessLevelRestricted
2013 546 0
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-AnalysisJournal of the National Cancer Institute
accessLevelRestricted
2013 577 0
Common bile duct adenocarcinoma in a patient with situs inversus totalis: report of a rare caseBMC research notes
accessLevelPublic
2012 665 274
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon CancerJournal of the National Cancer Institute
accessLevelPublic
2012 594 621
Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?Radiotherapy and oncology
accessLevelRestricted
2012 791 0
Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastasesWorld journal of surgery
accessLevelRestricted
2012 841 0
A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based studyAnnals of surgery
accessLevelRestricted
2012 793 0
Management of peritoneal carcinomatosis by surgical cytoreduction and hyperthermic intraperitoneal chemotherapySwiss knife
accessLevelPublic
2011 815 431
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010Annals of oncology
accessLevelRestricted
2011 620 0
Prise en charge du carcinome du canal analRevue médicale suisse
accessLevelRestricted
2011 566 0
Successful closure of anal cancer-related fistulas with upfront intra-arterial chemotherapy: a report of 8 casesDiseases of the colon & rectum
accessLevelRestricted
2011 577 0
Adjuvant radio-chemotherapy for extrahepatic biliary tract cancersBMC cancer
accessLevelPublic
2011 637 422
Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective studyJournal of gastroenterology and hepatology
accessLevelRestricted
2011 791 0
Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancerSchweizerische medizinische Wochenschrift
accessLevelPublic
2011 845 370
Thérapies ciblées en oncologie digestiveRevue médicale suisse
accessLevelRestricted
2011 545 0
Microsatellite instability, prognosis and drug sensitivity of stage II and III colorectal cancer: more complexity to the puzzleJournal of the National Cancer Institute
accessLevelRestricted
2011 678 1
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trialJournal of clinical oncology
accessLevelRestricted
2010 591 0
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discoveryThe oncologist
accessLevelRestricted
2010 626 0
Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodesAnnals of surgical oncology
accessLevelPublic
2010 816 286
Cancer de l'oesophage: traitement multidisciplinaireRevue médicale suisse
accessLevelRestricted
2010 786 0
Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03)Onkologie
accessLevelRestricted
2010 545 0
Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06)The oncologist
accessLevelRestricted
2010 627 0
Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancerWorld journal of gastroenterology
accessLevelRestricted
2010 459 0
Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastasesBritish journal of surgery
accessLevelRestricted
2009 764 0
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinibEuropean journal of cancer
accessLevelRestricted
2009 548 0
Cancer gastrique, une prise en charge multidisciplinaireRevue médicale suisse
accessLevelRestricted
2009 775 0
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)Annals of oncology
accessLevelRestricted
2009 634 0
Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trialClinical cancer research
accessLevelRestricted
2009 564 0
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?Supportive care in cancer
accessLevelRestricted
2009 529 0
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3Journal of clinical oncology
accessLevelRestricted
2009 620 0
'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastasesDigestive surgery
accessLevelRestricted
2008 861 0
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancerEuropean journal of cancer
accessLevelRestricted
2008 664 0
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer groupEuropean journal of cancer
accessLevelRestricted
2008 634 0
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKKAnnals of oncology
accessLevelRestricted
2008 633 0
Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity scoreAnnals of surgical oncology
accessLevelPublic
2008 958 308
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer ResearchJournal of clinical oncology
accessLevelRestricted
2007 578 0
Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumourEuropean journal of surgical oncology
accessLevelRestricted
2007 752 0
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancersInvestigational new drugs
accessLevelRestricted
2007 543 0
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgeryAnnals of oncology
accessLevelRestricted
2007 873 0
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006Annals of oncology
accessLevelPublic
2007 608 567
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaAnnals of oncology
accessLevelPublic
2007 589 1,279
Response from authors: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93: 872-878)British journal of surgery
accessLevelRestricted
2007 528 0
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005Annals of oncology
accessLevelPublic
2006 599 450
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primaryBritish journal of surgery
accessLevelRestricted
2006 796 0
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyBritish journal of cancer
accessLevelPublic
2006 635 283
Author's reply: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (British Journal of Surgery 2006; 93: 872–878)British journal of surgery
accessLevelRestricted
2006 442 0
Complete closure of cancer-related anovaginal and anoperineal fistulas in locally advanced anal canal carcinomas by upfront intra-arterial chemotherapy followed by combined radiochemotherapy: report of two casesDiseases of the colon & rectum
accessLevelRestricted
2006 927 0
Authors' reply: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg) 2006; 93; 872–878British journal of surgery
accessLevelRestricted
2006 502 0
Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II studyAnnals of oncology
accessLevelPublic
2005 686 336
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trialInternational journal of radiation oncology, biology, physics
accessLevelRestricted
2005 767 0
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective studyInternational journal of radiation oncology, biology, physics
accessLevelRestricted
2005 785 0
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicityAnnals of oncology
accessLevelPublic
2005 628 271
Nouveaux traitements systémiques dans le cancer du pancréas avancé : implications sur la survie et considérations médicoéconomiquesRevue médicale suisse
accessLevelRestricted
2005 506 1
Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trialThe cancer journal
accessLevelRestricted
2005 753 0
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II studyBritish journal of cancer
accessLevelPublic
2005 610 190
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trialAnnals of oncology
accessLevelPublic
2004 555 177
Docetaxal et cancer gastriqueBulletin du cancer
accessLevelRestricted
2004 440 0
Chemotherapeutic options in the management of anal cancerExpert opinion on pharmacotherapy
accessLevelRestricted
2004 765 0
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerAnnals of oncology
accessLevelPublic
2004 835 893
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancerBritish journal of cancer
accessLevelPublic
2003 616 232
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II studyAnnals of oncology
accessLevelPublic
2003 776 626
Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radio-frequency ablation under open-magnet MR guidance: initial resultsEuropean radiology
accessLevelRestricted
2003 586 1
Chemotherapy in gastric cancer: a never ending sagaAnnals of oncology
accessLevelRestricted
2003 528 0
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trialJournal of clinical oncology
accessLevelRestricted
2003 670 0
Docetaxel-based chemotherapy in the treatment of gastric cancerAnnals of oncology
accessLevelPublic
2003 687 248
Curative treatment of gastric cancer: towards a multidisciplinary approach?Critical reviews in oncology/hematology
accessLevelRestricted
2003 521 0
Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trialJournal of clinical oncology
accessLevelRestricted
2003 513 0
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)European journal of cancer
accessLevelRestricted
2002 541 0
Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trialInternational journal of radiation oncology, biology, physics
accessLevelRestricted
2002 684 0
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancerJournal of clinical oncology
accessLevelRestricted
2002 492 0
European experience of docetaxel and cisplatin in advanced gastric cancerGastric cancer
accessLevelRestricted
2002 505 0
Prise en charge multidisciplinaire du cancer colorectal héréditaireSwiss surgery
accessLevelRestricted
2001 854 0
Thermoablation percutanée de tumeurs hépatiques par radiofréquenceMédecine et hygiène
accessLevelRestricted
2001 726 0
Approche diagnostique et thérapeutique des métastases hépatiques d'origine colorectaleMédecine et hygiène
accessLevelRestricted
2000 736 0
Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potentialBritish journal of cancer
accessLevelPublic
2000 879 246
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)Annals of oncology
accessLevelPublic
2000 470 217
Approche multidisciplinaire du cancer rectalMédecine et hygiène
accessLevelRestricted
2000 665 5
Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapyAnnals of the New York Academy of Sciences
accessLevelRestricted
2000 572 1
Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility studyAnticancer research
accessLevelRestricted
2000 586 1
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialLancet
accessLevelRestricted
2000 539 0
Treatment of anal carcinoma in the elderly: feasibility and outcome of radical radiotherapy with or without concomitant chemotherapyCancer
accessLevelRestricted
1999 511 0
High dose etretinate and interferon-alpha--a phase I study in squamous cell carcinomas and transitional cell carcinomasActa oncologica
accessLevelPublic
1999 510 183
Les tumeurs bénognes et malignes associées à la polypose adénomateuse familialeMédecine et hygiène
accessLevelRestricted
1999 621 0
Wilms' tumor in the adult--report of a case and review of the literaturePathology, research and practice
accessLevelRestricted
1999 572 0
Effets du traitement néoadjuvant sur la chirurgie des tumeurs digestives avec extension locorégionaleMédecine et hygiène
accessLevelRestricted
1998 625 0
Colon cancers and peritoneal mesothelioma occurring 29 years after abdominal radiation for testicular seminoma. A case report and review of the literatureOncology
accessLevelRestricted
1998 633 0
Results of surgical resection of liver metastases from non-colorectal primariesBritish journal of surgery
accessLevelRestricted
1998 823 0
Syndrome de déficit immunitaire acquis, coccidiose chronique, et septicémie à Salmonella typhi murium chez un couple de zairois. Fonctions immunitaires et essai d'immunostimulation par la thymopentineSchweizerische medizinische Wochenschrift
1984 715 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack